Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1935-1945, doi:10.1016/j.jacc.2009.05.074
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, J. S.
Right arrow Articles by Berger, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, J. S.
Right arrow Articles by Berger, P. B.
Related Collections
Right arrowRelated Articles

The Relative Efficacy and Safety of Clopidogrel in Women and Men

A Sex-Specific Collaborative Meta-Analysis

Jeffrey S. Berger, MD*,*, Deepak L. Bhatt, MD, MPH{dagger},{ddagger}, Christopher P. Cannon, MD{ddagger}, Zhengming Chen, MBBS, DPhil§, Lixin Jiang, MBBS, MSc||, James B. Jones, PhD, MBA{dagger}{dagger}, Shamir R. Mehta, MD, Marc S. Sabatine, MD, MPH{ddagger},#, Steven R. Steinhubl, MD{dagger}{dagger}, Eric J. Topol, MD** and Peter B. Berger, MD{dagger}{dagger}

* New York University School of Medicine, New York, New York
{dagger} VA Boston Healthcare System, Boston, Massachusetts
{ddagger} Brigham and Women's Hospital, Boston, Massachusetts
§ University of Oxford, Oxford, England
|| Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China
McMaster University, Hamilton, Ontario, Canada
# Harvard Medical School, Boston, Massachusetts
** Scripps Translational Research Institute, La Jolla, California
{dagger}{dagger} Geisinger Clinic, Danville, Pennsylvania


Figure 1
View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Flow Diagram of the Trial Selection Process

 

Figure 2
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Effect of Clopidogrel Treatment on the Effect of Major Cardiovascular Events

Major cardiovascular events are defined as the composite of nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death. Pooled ORs are from a random-effects model. Sizes of data markers are proportional to the amount of data contributed by each trial. CHARISMA = Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance; CI = confidence interval; CLARITY–TIMI 28 = Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction 28; COMMIT = Clopidogrel and Metoprolol in Myocardial Infarction Trial; CREDO = Clopidogrel for the Reduction of Events During Observation; CURE = Clopidogrel in Unstable Angina to Prevent Recurrent Events; OR = odds ratio.

 

Figure 3
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Effect of Clopidogrel Treatment on the Effect of All-Cause Mortality

Pooled ORs are from a random-effects model. Sizes of data markers are proportional to the amount of data contributed by each trial. Abbreviations as in Figure 2.

 

Figure 4
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Effect of Clopidogrel Treatment on the Effect of Myocardial Infarction

Pooled ORs are from a random-effects model. Sizes of data markers are proportional to the amount of data contributed by each trial. Abbreviations as in Figure 2.

 

Figure 5
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Effect of Clopidogrel Treatment on the Effect of Stroke

Pooled ORs are from a random-effects model. Sizes of data markers are proportional to the amount of data contributed by each trial. Abbreviations as in Figure 2.

 

Figure 6
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Effect of Clopidogrel Treatment on the Effect of Major Bleeding

Pooled ORs are from a random-effects model. Sizes of data markers are proportional to the amount of data contributed by each trial. Abbreviations as in Figure 2.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement